The Cigna Group Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 46 rows in 2026. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2026-09-01: Reporting owner Evanko Brian C; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2026-08-05: Reporting owner Jones Nicole S; Form 4; Security Employee Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2026-08-04: Reporting owner Jones Nicole S; Form 4; Security Employee Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2026-07-09: Reporting owner Holgerson Bryan; Form 3; Security Employee Stock Option (Right to Buy); Transaction Holding.
CI insiders transactions against the stock price
Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-01 | Evanko Brian C Officer (See Remarks) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,716 6,716 owned after | $281.13 exercise price | $283.06 | 2026-09-03 |
| 2026-08-05 | Jones Nicole S Officer (See Remarks) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,301 0 owned after | $192.02 exercise price | $270.50 | 2026-08-06 |
| 2026-08-04 | Jones Nicole S Officer (See Remarks) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,045 1,301 owned after | $192.02 exercise price | $274.05 | 2026-08-06 |
| 2026-07-09 holding as of filing | Holgerson Bryan Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $197.35 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Holgerson Bryan Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $183.44 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Holgerson Bryan Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $192.02 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Holgerson Bryan Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $213.80 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Holgerson Bryan Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $227.02 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Holgerson Bryan Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $294.61 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Holgerson Bryan Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $336.48 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Holgerson Bryan Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $305.86 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Holgerson Bryan Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $287.55 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Kautzner Adam Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $183.44 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Kautzner Adam Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $192.02 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Kautzner Adam Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $213.80 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Kautzner Adam Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $227.02 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Kautzner Adam Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $294.61 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Kautzner Adam Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $336.48 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Kautzner Adam Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $305.86 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Kautzner Adam Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $287.55 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Sadler Jason D Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $294.61 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Sadler Jason D Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $336.48 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Sadler Jason D Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $305.86 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Sadler Jason D Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $287.55 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Perlberg Matthew Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $227.02 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Perlberg Matthew Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $294.61 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Perlberg Matthew Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $336.48 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Perlberg Matthew Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $305.86 exercise price | 2026-07-09 | ||
| 2026-07-09 holding as of filing | Perlberg Matthew Officer (See Remarks) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $287.55 exercise price | 2026-07-09 | ||
| 2026-06-12 | Kates Jamie G Officer (Chief Accounting Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −899 0 owned after | $152.89 exercise price | $298.00 | 2026-06-16 |
| 2026-05-13 | Cordani David Director, Officer (Chairman & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,458 0 owned after | $149.14 exercise price | $300.71 | 2026-05-14 |
| 2026-05-13 | Cordani David Director, Officer (Chairman & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,971 0 owned after | $197.35 exercise price | $300.71 | 2026-05-14 |
| 2026-05-12 | Cordani David Director, Officer (Chairman & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −103,595 15,458 owned after | $149.14 exercise price | $298.49 | 2026-05-14 |
| 2026-05-12 | Cordani David Director, Officer (Chairman & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −85,519 7,971 owned after | $197.35 exercise price | $298.49 | 2026-05-14 |
| 2026-04-03 holding as of filing | Nelson Andrea L Officer (EVP, General Counsl & Corp Sec) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $227.02 exercise price | 2026-04-03 | ||
| 2026-04-03 holding as of filing | Nelson Andrea L Officer (EVP, General Counsl & Corp Sec) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $294.61 exercise price | 2026-04-03 | ||
| 2026-04-03 holding as of filing | Nelson Andrea L Officer (EVP, General Counsl & Corp Sec) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $336.48 exercise price | 2026-04-03 | ||
| 2026-04-03 holding as of filing | Nelson Andrea L Officer (EVP, General Counsl & Corp Sec) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $305.86 exercise price | 2026-04-03 | ||
| 2026-04-03 holding as of filing | Nelson Andrea L Officer (EVP, General Counsl & Corp Sec) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $287.55 exercise price | 2026-04-03 | ||
| 2026-02-27 | Kates Jamie G Officer (Chief Accounting Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +657 657 owned after | $287.55 exercise price | $289.82 | 2026-03-03 |
| 2026-02-27 | Koka Durga Prasad Officer (EVP, Global CIO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,127 4,127 owned after | $287.55 exercise price | $289.82 | 2026-03-03 |
| 2026-02-27 | Neville Everett Officer (See Remarks) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,127 4,127 owned after | $287.55 exercise price | $289.82 | 2026-03-03 |
| 2026-02-27 | Jones Nicole S Officer (See Remarks) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,066 8,066 owned after | $287.55 exercise price | $289.82 | 2026-03-03 |
| 2026-02-27 | Evanko Brian C Officer (See Remarks) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,082 15,082 owned after | $287.55 exercise price | $289.82 | 2026-03-03 |
| 2026-02-27 | DENNISON ANN M Officer (EVP, CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,066 8,066 owned after | $287.55 exercise price | $289.82 | 2026-03-03 |
| 2026-02-27 | Cordani David Director, Officer (Chairman & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,516 37,516 owned after | $287.55 exercise price | $289.82 | 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |